HER-2阳性乳腺癌细胞与正常乳腺上皮细胞间circRNA表达谱的差异
研究提取HER-2阳性乳腺癌细胞SK-BR-3与正常乳腺细胞MCF10A的总RNA,用circRNA芯片检测表达谱,RT-qPCR验证差异circRNA,并行GO与KEGG分析。SK-BR-3中6584条circRNA上调、6254条下调,结论认为差异circRNA可能是潜在诊断或治疗靶标。
要点
- 与MCF10A相比,SK-BR-3细胞6584条circRNA上调、6254条下调。
- |log(2)FC|≥2的circRNA有348条,其中153条上调、195条下调。
- hsa_circRNA_074595、074598、100777经RT-qPCR验证与芯片趋势相符。
核心结论
- HER-2阳性乳腺癌细胞SK-BR-3中的circRNA表达谱与正常乳腺细胞MCF10A存在明显差异,差异circRNA可能是HER-2阳性乳腺癌有潜力的诊断或治疗靶标。
研究设计与样本
- 体外细胞研究:提取HER-2阳性乳腺癌细胞SK-BR-3与正常乳腺细胞MCF10A总RNA,经核糖核酸酶R富集circRNA后行Arraystar Human circRNA芯片杂交检测表达谱。
- 对差异倍数较大的circRNA用RT-qPCR验证,并对差异circRNA行GO与KEGG富集分析及circRNA-miRNA网络构建。
主要发现
- 与MCF10A细胞相比,SK-BR-3细胞中6584条circRNA表达水平上调、6254条表达水平下调。
- |log(2)FC|≥2的circRNA有348条,其中SK-BR-3细胞中153条上调、195条下调。
- |log(2)FC|>5的circRNA有8条,SK-BR-3细胞中上调5条:hsa_circRNA_074595(|log(2)FC|=7.84)、hsa_circRNA_074598(|log(2)FC|=6.50)、hsa_circRNA_085362(|log(2)FC|=5.86)、hsa_circRNA_101379(|log(2)FC|=5.71)、hsa_circRNA_406683(|log(2)FC|=5.34)。
- |log(2)FC|>5的circRNA中SK-BR-3细胞下调3条:hsa_circRNA_021714(|log(2)FC|=5.46)、hsa_circRNA_100777(|log(2)FC|=5.40)、hsa_circRNA_100796(|log(2)FC|=5.03)。
- RT-qPCR验证显示hsa_circRNA_074595、hsa_circRNA_074598和hsa_circRNA_100777的差异表达趋势与芯片结果相符。
关键数值与推荐
- GO分析显示差异表达circRNA显著富集于心脏发育生物学进程(P<0.001)、细胞黏附相关细胞组分(P<0.001)和蛋白质丝氨酸/苏氨酸激酶活性分子功能(P<0.001)。
- KEGG分析显示差异表达circRNA显著富集于PI3K-Akt信号通路。
临床怎么用
- 原文结论认为差异表达circRNA可能是HER-2阳性乳腺癌有潜力的诊断或治疗靶标,未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the differential expression profiles of circular RNA (circRNA) in human epidermal growth factor receptor 2 (HER-2) positive breast cancer cells and normal mammary epithelial cells, and to develop novel diagnostic and therapeutic markers for HER-2 positive breast cancer. Methods: Total RNA were extracted from HER-2 positive breast cancer cell SK-BR-3 and normal mammary epithelial cell MCF10A. RNA quality was detected using NanoDrop ND-1000. Rnase R was applied to remove linear RNA and enrich circRNAs. After amplification and reverse transcription into fluorescent complementary RNA (cRNA) using random primer, the labeled cRNAs were hybridized onto the Arraystar Human circRNA Arrays. The raw data were extracted and the acquired array images were subjected to quantile normalization followed by heat map and volcano plot analysis. The expression of circRNAs with large fold change was verified by real-time quantitative polymerase chain reaction (RT-qPCR). Finally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed in the differentially expressed circRNAs and circRNA-microRNA (miRNA) network was constructed. Results: The total RNA extracted from SK-BR-3 and MCF10A had high integrity and quality. The expression profiles of circRNA in SK-BR-3 and MCF10A cells were significantly different shown by fluorescent expression signals. Compared with MCF10A cells, there were 6 584 up-regulated circRNAs and 6254 down-regulated circRNAs in SK-BR-3 cells. There were 348 circRNAs with |log(2)FC|≥2, of which 153 were up-regulated and 195 were down-regulated. Moreover, 8 circRNAs with |log(2)FC|>5. Among them, 5 were up-regulated in SK-BR-3 cells, including hsa_circRNA_074595 (|log(2)FC|=7.84), hsa_circRNA_074598 (|log(2)FC|=6.50), hsa_circRNA_085362 (|log(2)FC|=5.86), hsa_circRNA_101379 (|log(2)FC|=5.71) and hsa_circRNA_406683 (|log(2)FC|=5.34); as well as 3 were down-regulated, including hsa_circRNA_021714 (|log(2)FC|=5.46), hsa_circRNA_100777 (|log(2)FC|=5.40), and hsa_circRNA_100796 (|log(2)FC|=5.03). The expression levels of hsa_circRNA_074595, hsa_circRNA_074598 and hsa_circRNA_100777 were further validated by RT-qPCR in consistent with the results of microarray. GO analysis showed that differentially expressed circRNAs were significantly enriched in the biological process of heart development (P<0.001), cellular component in the cell adhesion-related components (P<0.001), molecular function in protein serine/threonine kinase activity (P<0.001). KEGG analysis revealed that differentially expressed circRNAs were significantly enriched in the PI3K-Akt signaling pathway. Conclusions: The expression profile of circRNA in HER-2 positive breast cancer cells is significantly different from that in normal mammary epithelial cells. The differentially expressed circRNAs may be served as potential diagnostic or therapeutic targets for HER-2 positive breast cancer. 目的: 探讨环状RNA(circRNA)在人表皮生长因子受体2(HER-2)亚型乳腺癌细胞与正常乳腺细胞中的表达差异,为开发新型HER-2亚型乳腺癌诊断或治疗的标志物奠定基础。 方法: 分别提取HER-2亚型乳腺癌细胞SK-BR-3和正常乳腺细胞MCF10A的总RNA,使用NanoDrop ND-1000对总RNA进行质量检测,用核糖核酸酶R除去线性RNA并富集circRNA。采用随机引物法扩增富集的circRNA并转录成荧光带有荧光的互补RNA,与circRNA微阵列芯片上的circRNA探针进行杂交反应,通过扫描读取芯片上的荧光信号得到不同细胞中circRNA的表达谱。提取原始数据并对采集到的阵列图像进行分位数归一化及聚类分析和火山图分析。采用实时荧光定量聚合酶链反应(RT-qPCR)方法对差异倍数(FC)较大的circRNA进行鉴定。利用生物信息学方法,预测差异circRNA富集的基因本体论(GO)功能、京都基因与基因组百科全书(KEGG)通路和靶向微小RNA(miRNA)。 结果: 从SK-BR-3和MCF10A细胞中提取的总RNA完整性较好、纯度较高。荧光表达信号显示,SK-BR-3与MCF10A细胞中的circRNA表达谱明显不同。与MCF10A细胞相比,SK-BR-3细胞的6 584条circRNA表达水平上调,6 254条表达水平下调。|log(2)FC|≥2的circRNA有348条,其中153条上调,195条下调。|log(2)FC|≥5的circRNA有8条,其中5条上调,分别是hsa_circRNA_074595(|log(2)FC|=7.84)、hsa_circRNA_074598(|log(2)FC|=6.50)、hsa_circRNA_085362(|log(2)FC|=5.86)、hsa_circRNA_101379(|log(2)FC|=5.71)和hsa_circRNA_406683(|log(2)FC|=5.34);3条下调,分别是hsa_circRNA_021714(|log(2)FC|=5.46)、hsa_circRNA_100777(|log(2)FC|=5.40)和hsa_circRNA_100796(|log(2)FC|=5.03)。经RT-qPCR鉴定,hsa_circRNA_074595、hsa_circRNA_074598和hsa_circRNA_100777的差异表达趋势与芯片结果相符。GO分析显示,差异表达circRNA主要富集于心脏发育进程中(P<0.001),集中在细胞黏附相关功能区域(P<0.001),与蛋白质的丝氨酸/苏氨酸激酶调控活性显著相关(P<0.001)。KEGG分析显示,差异表达circRNA显著富集于PI3K-Akt信号通路。 结论: HER-2亚型乳腺癌细胞中的circRNA表达谱与正常乳腺细胞存在明显差异,这些差异表达circRNA可能是HER-2亚型乳腺癌有潜力的诊断或治疗靶标。.
引用
- Li LH, Xiao B, Muhetaer A, et al. [Differences in circRNA expression profiles between HER-2-positive breast cancer cells and normal mammary epithelial cells]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31137165. doi:10.3760/cma.j.issn.0253-3766.2019.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。